Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...
This advisory highlights more than 100 poster abstracts that will be presented at ASH 2025 involving researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback